Improving Outcomes Assessment in Chronic Graft versus Host Disease

Javier Adachi

Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru

Leukaemia

Hematology and hematologic malignancies

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Ralph D Sanderson

Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Effie W Petersdorf

Hematopoietic Stem Cell and Cord Blood Transplantation

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Aaron D Schimmer

Targeting Mitochondrial Protein Synthesis with Tigecycline for the Treatment of l

Leukaemia

Hematology and hematologic malignancies

Martine Extermann

Decision Models to Compare Treatments in Older Patients with AML

Leukaemia

Hematology and hematologic malignancies

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies